Approval to start FIH trial in Modena and Madrid

The sites in Modena (Italy) and Madrid (Spain) have received approval to execute the First-in-Human CORDIAL trial.

The CORDIAL survey for patients to investigate the preferences for new peritoneal dialysis devices is now available in English, Dutch, Spanish and Italian.

CORDIAL survey available in English and Dutch

The CORDIAL survey for patients to investigate the preferences for new peritoneal dialysis devices is now available in English and Dutch.

June newsletter

Our new newsletter is available!

The project CORDIAL has been extended from 3 years to 3.5 years. The current new end date is 31 December 2024. A second extension will be evaluated after summer 2024.

In May 2024, the fourth patient completed the first-in-human trial in the Netherlands. After summer we will continue the trial in Spain and Italy.

Nanodialysis at home dialysis congress Cologne

Nanodialysis presented the CORDIAL device at the home dialysis congress was held in Cologne (Germany), which was held o the 26th and 27th of April, 2024.

Start of First-in-Human study in Utrecht

This week we will start with the First-in-Human study in Utrecht.

Ethics committee approves start of First-in-Human investigation

Last week, the ethics committee approved the start of the First-in-Human investigation at the UMC Utrecht.

CORDIAL on ERA Congress Milan

Last week, Karin Gerritsen presented the WEAKID device and CORDIAL project on the ERA (European Renal Association) Congress in Milan, Italy.